Global Antiglaucoma Drugs Market Forecast And Growth Through COVID-19, Competitive Landscape, Segments, Key Regions Overview

The Business Research Company’s ‘Antiglaucoma Drugs Market - By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others), By Disease Condition Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma), By Prescription Type (OTC Drugs, Prescription Drugs), And By Region, Opportunities And Strategies – Global Antiglaucoma Drugs Market Forecast To 2030’ is the most comprehensive report available on this market. It covers 60 geographies and thus helps gain a truly global perspective of the market. The regional and country breakdowns section gives an analysis of the market in each geography as well as the size of the market by region and by country. It also compares the market’s historic and forecast growth while highlighting important trends and strategies that template market players can adopt.

The global antiglaucoma drugs market reached a value of nearly $6,591.8 million in 2019, having increased at a compound annual growth rate (CAGR) of 4.2% since 2015. The market is expected to decline from $6,591.8 million in 2019 to $5,191.2 million in 2020 at a rate of -21.2%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 5.0% to $6,659.2 million in 2021 and reach $ 7,345.6 million in 2023 at a CAGR of 2.7%. The market is expected to reach $8,089.0 million in 2025 at a CAGR of 4.9% and $10,767.9 million in 2030 at a CAGR of 5.9%.

Request For The Sample Of The Antiglaucoma Drugs Market Here:

The antiglaucoma drugs market consists of sales of antiglaucoma drugs and related services by entities (organizations, sole traders and partnerships) that produce antiglaucoma drugs to treat glaucoma conditions. Glaucoma is a group of eye conditions that lead to damage of the optic nerve of the eye causing blindness and impaired vision. Some of the major drugs include Xalantan, Lumigan, and Travatan among others.

Place A Direct Purchase Order Of The Antiglaucoma Drugs Report Here:

The antiglaucoma drugs market report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Some of the major players of the antiglaucoma drugs market are Allergen PLC., Novartis AG, Santen Pharmaceutical Co., Ltd., Akorn, Pfizer

The antiglaucoma drugs market is segmented by product type, disease condition type, prescription type and by geography.
By Product Type – The antiglaucoma drugs market can be segmented by product type

    • a. Alpha Agonist
    • b. Beta Blockers
    • c. Prostaglandin Analogs
    • d. Combined Medication
    • e. Others

By Disease Condition Type –? The antiglaucoma drugs market can be segmented by disease condition type

    • a. Open-Angle Glaucoma
    • b. Angle-Closure Glaucoma
    • c. Normal-Tension Glaucoma
    • d. Congenital Glaucoma
    • e. Other Types Of Glaucoma

By Prescription Type – The antiglaucoma drugs market can be segmented by prescription type

    • a. OTC Drugs
    • b. Prescription Drugs

Read More On The Global Antiglaucoma Drugs Market Report:

The antiglaucoma drugs market report describes and explains the global antiglaucoma drugs market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The antiglaucoma drugs report evaluates the market across each region and for the major economies within each region.

The countries covered in the global antiglaucoma drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global antiglaucoma drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Full Report Includes

  1. Executive Summary
  2. Report Structure
  3. Antiglaucoma Drugs Market Characteristics
  4. Antiglaucoma Drugs Market Product Analysis
  5. Antiglaucoma Drugs Market Supply Chain


  1. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market
  2. Market Background: Machinery Manufacturing Market
  3. Recommendations
  4. Appendix
  5. Copyright And Disclaimer

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database

The Business Research Company’s flagship product, Global Market Model is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293


Follow us on LinkedIn:

Follow us on Twitter:

Check out our Blog:

Check out our Global Market Model:

The Business Research Company


Oliver Guirdham (Managing Director) The Business Research Company Europe: +44 207 1930 708 Americas: +1 315 623 0293 Email:

Related Articles

Back to top button